This population-based study examines whether the use of dipeptidylpeptidase-4 inhibitors and glucagon-like peptide 1 analogues is associated with an increased risk of incident bile duct and gallbladder disease in patients with type 2 diabetes mellitus.
This population-based study examines the association between use of incretin-based drugs in patients with type 2 diabetes and development of acute pancreatitis.
This pharmacoepidemiology study uses claims data to investigate the association between intensive glucose-lowering treatment and severe hypoglycemia among adults with type 2 diabetes between 2001 and 2013.
This Teachable Moment provides an example of how patient-centered care and shared decision-making require a comprehensive and transparent discussion between patient and physician of known risks, benefits, costs, and burden of available and reasonable treatment options.
This retrospective cohort study analyzes diabetes screening prevalence and predictors of screening among adults in the California public mental health care system with severe mental illness taking antipsychotic medications.
This survey study of primary care physicians assessed perceived barriers to deintensifying treatment in patients with diabetes at risk for hypoglycemia.
This population-based cohort study of the longitudinal incidence of type 2 diabetes mellitus finds varying associations of incident diagnoses with neighborhood resources for healthy food and physical activity and with social environment in a population of multiethnic noninstitutionalized adults.
Findings of this cross-sectional analysis suggest that a substantial proportion of older adults with diabetes were potentially overtreated.
Investigation of 2 large prospective studies found that higher whole grain consumption is associated with lower total and cardiovascular disease mortality in US men and women.
This cross-sectional, retrospective cohort study found that veterans who receive glucose test strips through both the Department of Veterans Affairs and Medicare use more strips and are more likely to overuse strips.
This retrospective cohort study found that diabetes treatment with metformin reduced subsequent treatment intensification, without differences in rates of adverse clinical events. See also the Invited Commentary by Segal and Maruthur.
Vijan et al examine how treatment burden affects the benefits of intensive vs moderate glycemic control in patients with type 2 diabetes mellitus.
Bao et al examine the role of physical activity and television watching and other sedentary behaviors, and changes in these behaviors in the progression from gestational diabetes mellitus to type 2 diabetes mellitus. Hedderson and Ferrara provide an Invited Commentary.
Downing et al review news stories and biomedical literature discussing the Action to Control Cardiovascular Risk in Diabetes (ACCORD-Lipid) trial published within 15 months after results of the trial were presented.